Clinical guidelines of non-alcoholic fatty liver disease: A systematic review

World Journal of Gastroenterology

Volumn 22, Issue 36, 2016, Pages 8226-8233

  Zhu, Jin Zhou ^a   Hollis Hansen, Kelseanna ^b   Wan, Xing Yong ^a   Fei, Su Juan ^c   Pang, Xun Lei ^c   Meng, Fan Dong ^c   Yu, Chao Hui ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY AT BUFFALO   (United States)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; Management; Non alcoholic fatty liver disease; Systematic review; Treatment

Indexed keywords

ALGORITHM; APPRAISAL OF GUIDELINES FOR RESEARCH AND EVALUATION II; ASIA; ASSESSMENT OF HUMANS; BARIATRIC SURGERY; CHILE; CLINICAL ALGORITHM; CLINICAL PRACTICE; EUROPE; EVIDENCE BASED MEDICINE; FACTUAL DATABASE; HEALTH CARE POLICY; HUMAN; LIFESTYLE MODIFICATION; MASS SCREENING; NONALCOHOLIC FATTY LIVER; PATIENT SAFETY; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; GASTROENTEROLOGY; INTERNATIONAL COOPERATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PROCEDURES; STANDARDS; TREATMENT OUTCOME;

ALGORITHMS; EVIDENCE-BASED MEDICINE; GASTROENTEROLOGY; HUMANS; INTERNATIONAL COOPERATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84991108002     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i36.8226     Document Type: Review

References (30)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023 [PMID: 22488764 DOI: 10.1002/hep.25762]
2. European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu; European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016; 64: 1388-1402 [PMID: 27062661 DOI: 10.1016/ j.jhep.2015.11.004]
3. Marchesini G, Petta S, Dalle Grave R. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology 2016; 63: 2032-2043 [PMID: 26663351 DOI: 10.1002/hep.28392]
4. Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 2014; 59: 713-723 [PMID: 23929732 DOI: 10.1002/hep.26672]
5. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Metaanalytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84 [PMID: 26707365 DOI: 10.1002/ hep.28431]
6. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol 2013; 10: 307-318 [PMID: 23458891 DOI: 10.1038/nrgastro.2013.34]
7. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x]
8. Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M. Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials 2014; 9: 126-133 [PMID: 25514916 DOI: 10.2174/1574887109666141216111143]
9. Zhu JZ, Dai YN, Wang YM, Zhou QY, Yu CH, Li YM. Prevalence of Nonalcoholic Fatty Liver Disease and Economy. Dig Dis Sci 2015; 60: 3194-3202 [PMID: 26017679 DOI: 10.1007/ s10620-015-3728-3]
10. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012 [PMID: 19631508 DOI: 10.1016/j.jclinepi.2009.06.005]
11. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182: E839-E842 [PMID: 20603348 DOI: 10.1503/ cmaj.090449]
12. Loria P, Adinolfi LE, Bellentani S, Bugianesi E, Grieco A, Fargion S, Gasbarrini A, Loguercio C, Lonardo A, Marchesini G, Marra F, Persico M, Prati D, Baroni GS. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272-282 [PMID: 20171943 DOI: 10.1016/j.dld.2010.01.021]
13. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2013; 19: 325-348 [PMID: 24459637 DOI: 10.3350/cmh.2013.19.4.325]
14. LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Peñaranda MM, Ramos JF, Sarin S, Stimac D, Thomson AB, Umar M, Krabshuis J, LeMair A. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014; 48: 467-473 [PMID: 24921212 DOI: 10.1097/mcg.0000000000000116]
15. Weiß J, Rau M, Geier A. Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int 2014; 111: 447-452 [PMID: 25019921 DOI: 10.3238/ arztebl.2014.0447]
16. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013; 58: 593-608 [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005]
17. Spengler EK, Loomba R. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Mayo Clin Proc 2015; 90: 1233-1246 [PMID: 26219858 DOI: 10.1016/ j.mayocp.2015.06.013]
18. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of nonalcoholic fatty liver disease. A critical appraisal. J Hepatol 2013; 58: 1007-1019 [PMID: 23183525 DOI: 10.1016/j.jhep.2012.11.021]
19. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33 [PMID: 17081293 DOI: 10.1186/1471-230X-6-33]
20. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010; 42: 503-508 [PMID: 19766548 DOI: 10.1016/ j.dld.2009.08.002]
21. Marchesini G, Mazzotti A. NAFLD incidence and remission: only a matter of weight gain and weight loss? J Hepatol 2015; 62: 15-17 [PMID: 25450705 DOI: 10.1016/j.jhep.2014.10.023]
22. Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology 2015; 61: 1392-1405 [PMID: 25557690 DOI: 10.1002/hep.27678]
23. Wilkins T, Tadkod A, Hepburn I, Schade RR. Nonalcoholic fatty liver disease: diagnosis and management. Am Fam Physician 2013; 88: 35-42 [PMID: 23939604]
24. Sint Nicolaas J, de Jonge V, de Man RA, ter Borg F, Cahen DL, Moolenaar W, Stolk MF, van Tilburg AJ, Valori RM, van Leerdam ME, Kuipers EJ. The Global Rating Scale in clinical practice: a comprehensive quality assurance programme for endoscopy departments. Dig Liver Dis 2012; 44: 919-924 [PMID: 22840567 DOI: 10.1016/j.dld.2012.06.021]
25. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-787 [PMID: 17565630 DOI: 10.1111/ j.1440-1746.2007.05001.x]
26. Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 2008; 9: 108-112 [PMID: 18419645 DOI: 10.1111/j.1751-2980.2008.00331.x]
27. Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, Chan LY. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 163-166). J Dig Dis 2011; 12: 38-44 [PMID: 21276207 DOI: 10.1111/j.1751-2980.2010.00476.x]
28. Gao X, Fan JG. Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. J Diabetes 2013; 5: 406-415 [PMID: 23560695 DOI: 10.1111/1753-0407.12056]
29. Arab JP, Candia R, Zapata R, Muñoz C, Arancibia JP, Poniachik J, Soza A, Fuster F, Brahm J, Sanhueza E, Contreras J, Cuellar MC, Arrese M, Riquelme A. Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review. World J Gastroenterol 2014; 20: 12182-12201 [PMID: 25232252 DOI: 10.3748/wjg.v20.i34.12182]
30. Watanabe S, Hashimoto E, Ikejima K, Uto H, Ono M, Sumida Y, Seike M, Takei Y, Takehara T, Tokushige K, Nakajima A, Yoneda M, Saibara T, Shiota G, Sakaida I, Nakamuta M, Mizuta T, Tsubouchi H, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. J Gastroenterol 2015; 50: 364-377 [PMID: 25708290 DOI: 10.1007/s00535-015-1050-7]